OncoAssure announces clinical validation of prostate cancer test
Sanatate
UCD Research and Innovation Jan 21 2025 OncoAssure Ltd, an Irish medical diagnostic company, today announced the publication of new data, in the British Journal of Urology International Compass ( BJUI Compass ), which demonstrates the clinical validation of OncoAssure Prostate, a novel biopsy test which provides improved estimation of a patient’s risk of prostate cancer recurrence and allows for optimal treatment selection. Currently, the US is the major market for prognostic cancer tests,
din zilele anterioare